Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Launched by M.D. ANDERSON CANCER CENTER · Jun 14, 2023

Keywords

ClinConnect Summary

This clinical trial is designed to help caregivers of patients with advanced cancer, specifically those whose loved ones have stage IV solid tumors. The goal is to understand the experiences and emotional well-being of these caregivers and to develop a brief treatment program aimed at improving their positive feelings and overall mental health. The study is not yet recruiting participants, but when it does, it will welcome both men and women aged 18 and older who have been living with the cancer patient for more than six months.

To be eligible for the trial, caregivers must be able to read and speak English and have access to a phone or the internet for participating in the study activities. They will need to give their consent to be part of the study and be willing to follow its procedures. However, caregivers who are currently receiving therapy, or those who may be vulnerable due to certain conditions, will not be able to participate. If you join this study, you can expect to engage in activities aimed at improving your emotional well-being while sharing your experiences as a caregiver, which can help shape better support for others in similar situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Provision of signed and dated informed consent form
• • Stated willingness to comply with all study procedures and availability for the duration of the study
• • Males and female adults ≥18 years
• • Able to read and speak English
• • Caregiver of a patient diagnosed with stage IV solid malignancy, with whom they have been residing for \>6 months
• • Access to necessary resources for participating in a technology-based intervention (i.e., telephone, internet access)
• Exclusion Criteria:
• • Current participation in consistent (self-defined) psychotherapy
• • Caregivers who are considered part of a vulnerable population (i.e. cognitively impaired (self-reported or patient-reported), pregnant, military personnel) will not be eligible.